Related Experiment Video
Updated: Apr 17, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
A novel target for oral cancer chemoprevention? Notch quite, yet…
William N William1, Adel K El-Naggar2
1Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. wnwillia@mdanderson.org.
Abstract:
The two major goals of oral cancer chemoprevention efforts are the ability to segregate the high-risk patients and the identification of an effective pharmacologic agent that halts progression to invasive cancer. Considerable progress has recently been achieved in profiling invasive head and neck squamous cell carcinomas, particularly with the use of high-throughput technologies. A similar molecular characterization of potentially malignant oral epithelial lesions (OPML; leukoplakia and erythroplakia) is yet to be accomplished. It is postulated, though, that molecular profiling could lead to the discovery of novel markers of cancer risk that could also serve as potential targets for chemoprevention. In this perspective, we comment on the work by Izumchenko and colleagues that reports a high prevalence of NOTCH1 gain-of-function mutations in Chinese patients with OPMLs. Although additional studies are needed to validate the findings, the study is the first to link alterations in this gene in oral premalignancy. These findings could serve as a first prototype of a single gene mutation as a potential target in clinical chemoprevention setting.
Insights
Researchers found NOTCH1 gene mutations in oral potentially malignant epithelial lesions (OPML). This discovery could lead to new chemoprevention strategies for oral cancer by targeting specific gene alterations.
Area of Science:
- Oncology
- Genetics
- Oral Medicine
Background:
- Oral cancer chemoprevention aims to identify high-risk individuals and effective agents to prevent invasive cancer.
- High-throughput technologies have advanced the molecular profiling of invasive head and neck squamous cell carcinomas.
- Molecular characterization of oral potentially malignant epithelial lesions (OPML) is needed to discover novel cancer risk markers.
Purpose of the Study:
- To comment on the significance of identifying molecular alterations in OPML.
- To highlight the potential of molecular profiling for discovering chemoprevention targets.
- To discuss the implications of NOTCH1 mutations in oral premalignancy.
Main Methods:
- Review and commentary on existing research, specifically the work by Izumchenko and colleagues.
- Analysis of high-throughput data for molecular characterization of OPML.
- Focus on genetic mutations, particularly gain-of-function mutations.
Main Results:
- The study by Izumchenko et al. reported a high prevalence of NOTCH1 gain-of-function mutations in Chinese patients with OPMLs.
- This is the first study to link NOTCH1 gene alterations to oral premalignancy.
- Findings suggest NOTCH1 mutations as a potential marker for oral cancer risk.
Conclusions:
- Molecular profiling of OPML is crucial for advancing chemoprevention strategies.
- NOTCH1 mutations represent a potential target for oral cancer chemoprevention.
- Further studies are required to validate these findings and their clinical applicability.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Notch Signaling Pathway
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Cancer Prevention
Some...
Cancer Prevention
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

